Aytu Biopharma, Inc. (AYTU)
2.57
-0.09
(-3.38%)
USD |
NASDAQ |
Apr 07, 16:00
2.60
+0.03
(+1.17%)
Pre-Market: 20:00
Aytu Biopharma EPS Diluted (Quarterly) : -1.055 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Altimmune, Inc. | -0.2719 |
| Actinium Pharmaceuticals, Inc. | -0.1904 |
| Aldeyra Therapeutics, Inc. | -0.1074 |
| Annovis Bio, Inc. | -0.3964 |
| BioAtla, Inc. | -8.181 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.58M |
| Revenue (Quarterly) | 15.16M |
| Total Expenses (Quarterly) | 25.75M |
| Enterprise Value | 19.66M |
| Gross Profit Margin (Quarterly) | 59.99% |
| Profit Margin (Quarterly) | -69.79% |
| Earnings Yield | -152.8% |
| Normalized Earnings Yield | -118.91 |